Cargando…

Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia

Classic congenital adrenal hyperplasia affects approximately 1 in 15,000 children. Current treatment strategies using multiple daily doses of hydrocortisone lead to suboptimal outcomes. We tested the hypothesis that nocturnal administration of dexamethasone will suppress the hypothalamic-pituitary-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dauber, Andrew, Feldman, Henry A., Majzoub, Joseph A.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943098/ https://www.ncbi.nlm.nih.gov/pubmed/20871859 http://dx.doi.org/10.1155/2010/347636

Ejemplares similares

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2021)

Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasia
por: Karunasena, Nayananjani, et al.
Publicado: (2017)

Differential effects of hydrocortisone, prednisone, and dexamethasone on hormonal and pharmacokinetic profiles: a pilot study in children with congenital adrenal hyperplasia
por: Nebesio, Todd D., et al.
Publicado: (2016)

Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German/Austrian registry
por: Hoyer-Kuhn, Heike, et al.
Publicado: (2021)

Normal Intelligence in Female and Male Patients with Congenital Adrenal Hyperplasia
por: Berenbaum, Sheri A., et al.
Publicado: (2010)

Long-term prednisone versus hydrocortisone treatment in children with classic congenital adrenal hyperplasia (CAH) and a brief review of the literature
por: Ahmed, Shaymaa Elsayed Abdel Meguid, et al.
Publicado: (2019)

Alterations in Hydrocortisone Pharmacokinetics in a Patient With Congenital Adrenal Hyperplasia Following Bariatric Surgery
por: Mallappa, Ashwini, et al.
Publicado: (2017)

Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia
por: Falhammar, Henrik, et al.
Publicado: (2012)

Access to fludrocortisone and to hydrocortisone in children with congenital adrenal hyperplasia in the WHO Eastern Mediterranean Region: it takes a village…
por: Rowlands, Amanda, et al.
Publicado: (2021)

Sexual Well-Being in Adult Male Patients with Congenital Adrenal Hyperplasia
por: Dudzińska, Bogna, et al.
Publicado: (2014)

Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE)
por: Han, Thang S, et al.
Publicado: (2013)

Nonclassic Congenital Adrenal Hyperplasia
por: Witchel, Selma Feldman, et al.
Publicado: (2010)

Results of the Prolonged Use of Subcutaneous Continuous Infusion of Hydrocortisone in a Man with Congenital Adrenal Hyperplasia
por: Sonnet, Emmanuel, et al.
Publicado: (2011)

RF09 | PSAT70 Comparison of Prednisolone Versus Modified-release Hydrocortisone (Efmody) in the Treatment of Congenital Adrenal Hyperplasia (CAH)
por: Merke, Deborah P, et al.
Publicado: (2022)

Dexamethasone Therapy of Congenital Adrenal Hyperplasia and the Myth of the “Growth Toxic” Glucocorticoid
por: Rivkees, Scott A.
Publicado: (2010)

Would Cortisol Measurements Be a Better Gauge of Hydrocortisone Replacement Therapy? Congenital Adrenal Hyperplasia as an Exemplar
por: Hindmarsh, Peter C, et al.
Publicado: (2020)

Pain and Stress Response during Intravenous Access in Children with Congenital Adrenal Hyperplasia: Effects of EMLA and Nitrous Oxide Treatment
por: Ekbom, K.
Publicado: (2017)

OR25-02 A Phase 3 Study of a Modified-Release Hydrocortisone in the Treatment of Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2020)

Low-Dose Dexamethasone Therapy from Infancy of Virilizing Congenital Adrenal Hyperplasia
por: Rivkees, Scott A., et al.
Publicado: (2009)

Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
por: Tomalik-Scharte, Dorota, et al.
Publicado: (2010)

Real-World Estimates of Adrenal Insufficiency–Related Adverse Events in Children With Congenital Adrenal Hyperplasia
por: Ali, Salma R, et al.
Publicado: (2020)

Testicular adrenal rest tumors in children with congenital adrenal hyperplasia
por: Al-Ghamdi, Waad M., et al.
Publicado: (2021)

Influence of the A3669G Glucocorticoid Receptor Gene Polymorphism on the Metabolic Profile of Pediatric Patients with Congenital Adrenal Hyperplasia
por: Moreira, Ricardo P. P., et al.
Publicado: (2014)

Growth characteristics in children with congenital adrenal hyperplasia
por: Alzanbagi, Mashael A., et al.
Publicado: (2018)

Prenatal Dexamethasone for Congenital Adrenal Hyperplasia: An Ethics Canary in the Modern Medical Mine
por: Dreger, Alice, et al.
Publicado: (2012)

An update on the long-term outcomes of prenatal dexamethasone treatment in congenital adrenal hyperplasia
por: van’t Westeinde, Annelies, et al.
Publicado: (2023)

Histrelin Implantation and Growth Outcomes in Children With Congenital Adrenal Hyperplasia: An Institutional Experience
por: Swendiman, Robert A, et al.
Publicado: (2019)

A pilot study on the effect of three hydrocortisone dosing regimen on 17 hydroxyprogesterone levels in patients with congenital adrenal hyperplasia
por: Salud, Josephine Leiya Marie F, et al.
Publicado: (2013)

SUN-358 Dual Release Hydrocortisone as a New Treatment for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Simeoli, Chiara, et al.
Publicado: (2019)

Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach
por: Michelet, Robin, et al.
Publicado: (2023)

Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency
por: Nilsson, A G, et al.
Publicado: (2014)

Congenital adrenal hyperplasia
por: Dessinioti, Cleo, et al.
Publicado: (2009)

Congenital Adrenal Hyperplasia
por: Speiser, Phyllis W.
Publicado: (2015)

Prevalence of nephrocalcinosis in children with congenital adrenal hyperplasia
por: Madihi, Yahya, et al.
Publicado: (2022)

Cognitive functions in children with congenital adrenal hyperplasia
por: Amr, Nermine Hussein, et al.
Publicado: (2019)

SAT-009 Proof of Concept That Corticosterone Has a Higher Therapeutic Index Than Hydrocortisone in Patients with Congenital Adrenal Hyperplasia
por: Kyle, Catriona, et al.
Publicado: (2019)

Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents With Congenital Adrenal Hyperplasia
por: Harasymiw, Lauren A, et al.
Publicado: (2020)

Treatment of congenital adrenal hyperplasia in children aged 0–3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure
por: Neumann, Uta, et al.
Publicado: (2022)

Infants With Congenital Adrenal Hyperplasia Are at Risk for Hypercalcemia, Hypercalciuria, and Nephrocalcinosis
por: Schoelwer, Melissa J., et al.
Publicado: (2017)

Congenital lipoid adrenal hyperplasia
por: Kim, Chan Jong
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6018rbdhjpsellrltjhfibdpcb